A blood test can help diagnose bipolar disorder

This study marks a paradigm for identifying bipolar disorder and improving treatment effectiveness. It will also reduce the forecast lag from eight years to one month. This study receives European funding and was carried out by the above-mentioned hospitals and two centers in France and Denmark.

Through a blood test, it can be detected when the brain is not functioning properly as it emits detectable signals as biomarkers. They detect changes in RNA molecules, and from a blood sample, these sequences can be analyzed in the laboratory and indicate whether undetected bipolar depression exists. Result The test takes 24 days.This represents a radical advance in reducing the time to predict disease.

According to research, bipolar disorder affects 2% to 3% of the world’s population. World Health Organization. Diagnosis of this mood disorder is complex and usually requires a very lengthy process that can last several years.

The study highlights the importance of emphasizing the need to distinguish between depression and bipolarity. The symptoms of both diseases are similar, but require completely different treatments. The main delay factor is misdiagnosis confusing bipolarity with depression.

The end result is that the patient is at greater risk addiction, hospitalization or suicide, as well as a deterioration in their quality of life. myEDIT-B is expected to be validated in Spain by the end of 2024 and will have a reliability of 90%. Once CE certified, the researchers hope the test will be included in the health system’s portfolio of services.

To take a blood test, the patient must provide a photograph severe and severe depression considered a disease. MyEDIT-B is critical for differentiating depressions that are caused by genetic and biological causes from depressions that are indirect.